The provocative findings of a small Chinese randomized controlled trial that compared a full-dose and a half-dose regimen of lytics in patients with acute pulmonary embolism raise many questions and ...
Marc Simon has reviewed the fundamental concepts underlying the diagnosis and therapy of a variety of clinical conditions associated with right ventricular (RV) failure (Simon, M. A. Assessment and ...
Pulmonary embolism (PE) is caused by emboli, which have originated from venous thrombi, travelling to and occluding the arteries of the lung. PE is the most dangerous form of venous thromboembolism, ...
Researchers report that a new nuclear medicine tracer may allow better diagnosis of acute venous thromboembolism (VTE). Acute VTE is a disease that includes deep-vein thrombosis and its complication, ...
Mouse and human data suggest endothelial ALOX15 and its lipids may help turn some lung clots into protection in sepsis lung injury, highlighting future therapeutic opportunities.
Internal Jugular, Subclavian, and Axillary Deep Venous Thrombosis and the Risk of Pulmonary Embolism
The objective of this study was to investigate the risk of acute internal jugular, subclavian, and axillary deep venous thrombosis (upper torso DVT [UTDVT]) and pulmonary embolism (PE) and the role of ...
Background. Infections are risk factors for venous thromboembolism (VTE), especially if severe and acute. The role of chronic infections such as active tuberculosis is ill defined, although several ...
A first-in-human study featured in the February issue of The Journal of Nuclear Medicine reports that the novel positron emission tomography/computed tomography (PET/CT) tracer 18F-GP1 showed ...
Stakeholders concurred that the occurrence of VTE events is a significant public health concern. According to Ralph J. Riello III, PharmD, “It is a problem often that hospitals do not know that they ...
Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The AMPLIFY investigators randomized 5,395 patients with acute venous ...
The factor Xa inhibitor apixaban is noninferior to conventional therapy with enoxaparin and a vitamin K antagonist in patients with acute venous thromboembolism (VTE). The study, published online July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback